Gilmour SK - Search Results

1

Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.

Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Gamble LD, Cheng NC, Liu K, Reese M, Corrigan KA, Ziegler DS, Webber H, Hayes CS, Pawel B, Marshall GM, Zhao H, Gilmour SK, Norris MD, Hogarty MD. Evageliou NF, et al. Among authors: gilmour sk. Clin Cancer Res. 2016 Sep 1;22(17):4391-404. doi: 10.1158/1078-0432.CCR-15-2539. Epub 2016 Mar 24. Clin Cancer Res. 2016. PMID: 27012811

2

ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

Hogarty MD, Norris MD, Davis K, Liu X, Evageliou NF, Hayes CS, Pawel B, Guo R, Zhao H, Sekyere E, Keating J, Thomas W, Cheng NC, Murray J, Smith J, Sutton R, Venn N, London WB, Buxton A, Gilmour SK, Marshall GM, Haber M. Hogarty MD, et al. Among authors: gilmour sk. Cancer Res. 2008 Dec 1;68(23):9735-45. doi: 10.1158/0008-5472.CAN-07-6866. Cancer Res. 2008. PMID: 19047152 Free PMC article.

3

Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.

Bassiri H, Benavides A, Haber M, Gilmour SK, Norris MD, Hogarty MD. Bassiri H, et al. Among authors: gilmour sk. Transl Pediatr. 2015 Jul;4(3):226-38. doi: 10.3978/j.issn.2224-4336.2015.04.06. Transl Pediatr. 2015. PMID: 26835380 Free PMC article. Review.

4

Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.

Hayes CS, DeFeo K, Lan L, Paul B, Sell C, Gilmour SK. Hayes CS, et al. Among authors: gilmour sk. Oncogene. 2006 Mar 9;25(10):1543-53. doi: 10.1038/sj.onc.1209198. Oncogene. 2006. PMID: 16278677

5

Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors.

Hobbs CA, Paul BA, Gilmour SK. Hobbs CA, et al. Among authors: gilmour sk. Cancer Res. 2002 Jan 1;62(1):67-74. Cancer Res. 2002. PMID: 11782361

6

Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.

Lan L, Trempus C, Gilmour SK. Lan L, et al. Among authors: gilmour sk. Cancer Res. 2000 Oct 15;60(20):5696-703. Cancer Res. 2000. PMID: 11059762

7

Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.

Wei G, DeFeo K, Hayes CS, Woster PM, Mandik-Nayak L, Gilmour SK. Wei G, et al. Among authors: gilmour sk. Cancer Res. 2008 Apr 1;68(7):2214-22. doi: 10.1158/0008-5472.CAN-07-5030. Cancer Res. 2008. PMID: 18381427 Free PMC article.

8

B23 is a downstream target of polyamine-modulated CK2.

Lawson K, Larentowicz L, Laury-Kleintop L, Gilmour SK. Lawson K, et al. Among authors: gilmour sk. Mol Cell Biochem. 2005 Jun;274(1-2):103-14. doi: 10.1007/s11010-005-3066-4. Mol Cell Biochem. 2005. PMID: 16342411

9

Tip60 protein isoforms and altered function in skin and tumors that overexpress ornithine decarboxylase.

Hobbs CA, Wei G, DeFeo K, Paul B, Hayes CS, Gilmour SK. Hobbs CA, et al. Among authors: gilmour sk. Cancer Res. 2006 Aug 15;66(16):8116-22. doi: 10.1158/0008-5472.CAN-06-0359. Cancer Res. 2006. PMID: 16912189

10

Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.

Alexander ET, Mariner K, Donnelly J, Phanstiel O 4th, Gilmour SK. Alexander ET, et al. Among authors: gilmour sk. Mol Cancer Ther. 2020 Oct;19(10):2012-2022. doi: 10.1158/1535-7163.MCT-19-1116. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747421 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters